SSSimon Svedman

Simon Svedman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Simon Svedman has a total of 20 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Acute Achilles tendon rupture : predictors for outcome and plan for intervention

    by Simon Svedman

    Acute Achilles tendon rupture (ATR) is a common tendon injury. Regardless of the initial treatment, many patients experience persistent symptoms and muscle weakness following ATR. This thesis aims to improve patient outcomes by identifying novel, modifiable, or preventable factors and subsequently plan an intervention study. The research questions addressed are: 1) What are the current incidence and treatment rates of ATR in Sweden? 2) Does the time between injury and surgical treatment affect patient outcomes after ATR? 3) Does the development of a deep venous thrombosis (DVT) during ATR immobilization impair patient outcomes? 4) To what extent does muscle deconditioning occur six weeks post-ATR, and how does it impact patient outcomes at one year?To investigate trends in ATR incidence and treatment in Sweden, a nationwide register-based study was conducted, including all adult in- and out-patients between 2002 and 2021. Over this period, the long-term incidence of ATR increased by 45%, from 28.8 in 2002 to 41.7 in 2021 per 100 000 person-years (p72 hours. Among those operated within 48 hours, 71% achieved a "good outcome", defined as an Achilles Tendon Total Rupture Score (ATRS) greater than 80. In contrast, only 44% of patients operated on after 72 hours reached this outcome. Additionally, the incidence of adverse events was significantly lower in patients treated within 48 hours compared those treated between 48 and 72 hours, and beyond 72 hours (1.4%, 11%, and 14.8% respectively).The effect of DVT on patient outcomes was then investigated in 251 surgically treated ATR patients who underwent duplex ultrasound screening for DVT at discontinuation of immobilization. The overall incidence of DVT was 49% (122 out of 251). Patients who developed a DVT reported significantly lower ATRS one- year post-injury compared to those without DVT (ATRS 76 vs. 83, p<0.01). Moreover, patients with a DVT did not reach a "good outcome" to the same extent as patients without a DVT (51% vs 67%).To assess muscle deconditioning post-ATR and its impact in one-year outcomes, 15 patients underwent computed tomography scans six weeks after lower leg immobilization. Cross-sectional area (CSA) and radiological attenuation (RA) were measured, with lower values indicating muscle loss and muscle fat infiltration (MFI), respectively. CSA and RA values were significantly lower in 2 out of 7 and 6 out of 7 muscles respectively, in the injured compared to the uninjured lower leg. RA was most notably reduced in the triceps surae and its individual muscles, while CSA was only significantly reduced in the lateral and medial gastrocnemius, with decreases of 23% and 20% respectively. Notably, lower RA values, i.e. increased MFI, in the injured triceps surae were associated with impaired functional outcomes one-year post-injury, while CSA reductions did not demonstrated any significant relationship with outcomes.Given these findings, efforts should be made to mitigate the development of DVT and MFI during ATR immobilization. Intermittent pneumatic compression (IPC) is an intervention that aims to enhance blood circulation, decrease inflammation and provide muscle stimulation during immobilization. The Swedish multicenter Trial of Outpatient Prevention of Leg Clots (STOP Leg Clots) is a prospective multicenter superiority trial, investing IPC during lower leg immobilization after ATR and ankle fracture. The primary aim to reduce venous thromboembolic events (VTE), while secondary aims include reducing MFI, enhancing healing and improving patient outcomes. VTE is defined as either symptomatic pulmonary embolism or symptomatic DVT, or ultrasound detected DVT detected at immobilization discontinuation. Patients will be randomized to the intervention or treatment-as-usual. With 90% power and an estimated 8% absolute risk reduction, a sample size of 700 patients per arm was calculated.ConclusionThe incidence of ATR in Sweden has significantly increase and continues to rise. Delayed surgical intervention negatively impacts patient-reported outcomes and should be accounted for when comparing treatment strategies. ATR immobilization increases the risk of both DVT and MFI, significantly impacting patient outcomes. Preventive measures should be prioritized to optimize patient outcomes. The STOP Leg clots study, a ongoing prospective multicenter trial, aims to mitigate these negative effects and improve long-term recovery in ATR patients.List of scientific papersI. Svedman S, Marcano A, Ackermann PW, Felländer-Tsai L, Berg HE. Acute Achilles Tendon Ruptures Between 2002-2021: Sustained Increased Incidence, Surgical Decline and Prolonged Delay to Surgery - A Nationwide Study of 53,688 Patients in Sweden. https://doi.org/10.1136/bmjsem-2024-001960II. Svedman S, Juthberg R, Edman G, Ackermann PW. Reduced Time to Surgery Improves Patient-Reported Outcome and decreases the Risk of Adverse Events after Achilles Tendon Rupture. Am. J Sports Med. 2018, 46(12), 2929-2934.https://doi.org/10.1177/0363546518793655III. Svedman S, Edman G, Ackermann PW. Deep venous thrombosis after Achilles tendon rupture is associated with poor patient- reported outcome. Knee Surg Sports Traumatol Arthrosc....

  • Open Access

    Acute Achilles tendon rupture : predictors for outcome and plan for intervention

    by Simon Svedman

    Acute Achilles tendon rupture (ATR) is a common tendon injury. Regardless of the initial treatment, many patients experience persistent symptoms and muscle weakness following ATR. This thesis aims to improve patient outcomes by identifying novel, modifiable, or preventable factors and subsequently plan an intervention study. The research questions addressed are: 1) What are the current incidence and treatment rates of ATR in Sweden? 2) Does the time between injury and surgical treatment affect patient outcomes after ATR? 3) Does the development of a deep venous thrombosis (DVT) during ATR immobilization impair patient outcomes? 4) To what extent does muscle deconditioning occur six weeks post-ATR, and how does it impact patient outcomes at one year?To investigate trends in ATR incidence and treatment in Sweden, a nationwide register-based study was conducted, including all adult in- and out-patients between 2002 and 2021. Over this period, the long-term incidence of ATR increased by 45%, from 28.8 in 2002 to 41.7 in 2021 per 100 000 person-years (p72 hours. Among those operated within 48 hours, 71% achieved a "good outcome", defined as an Achilles Tendon Total Rupture Score (ATRS) greater than 80. In contrast, only 44% of patients operated on after 72 hours reached this outcome. Additionally, the incidence of adverse events was significantly lower in patients treated within 48 hours compared those treated between 48 and 72 hours, and beyond 72 hours (1.4%, 11%, and 14.8% respectively).The effect of DVT on patient outcomes was then investigated in 251 surgically treated ATR patients who underwent duplex ultrasound screening for DVT at discontinuation of immobilization. The overall incidence of DVT was 49% (122 out of 251). Patients who developed a DVT reported significantly lower ATRS one- year post-injury compared to those without DVT (ATRS 76 vs. 83, p<0.01). Moreover, patients with a DVT did not reach a "good outcome" to the same extent as patients without a DVT (51% vs 67%).To assess muscle deconditioning post-ATR and its impact in one-year outcomes, 15 patients underwent computed tomography scans six weeks after lower leg immobilization. Cross-sectional area (CSA) and radiological attenuation (RA) were measured, with lower values indicating muscle loss and muscle fat infiltration (MFI), respectively. CSA and RA values were significantly lower in 2 out of 7 and 6 out of 7 muscles respectively, in the injured compared to the uninjured lower leg. RA was most notably reduced in the triceps surae and its individual muscles, while CSA was only significantly reduced in the lateral and medial gastrocnemius, with decreases of 23% and 20% respectively. Notably, lower RA values, i.e. increased MFI, in the injured triceps surae were associated with impaired functional outcomes one-year post-injury, while CSA reductions did not demonstrated any significant relationship with outcomes.Given these findings, efforts should be made to mitigate the development of DVT and MFI during ATR immobilization. Intermittent pneumatic compression (IPC) is an intervention that aims to enhance blood circulation, decrease inflammation and provide muscle stimulation during immobilization. The Swedish multicenter Trial of Outpatient Prevention of Leg Clots (STOP Leg Clots) is a prospective multicenter superiority trial, investing IPC during lower leg immobilization after ATR and ankle fracture. The primary aim to reduce venous thromboembolic events (VTE), while secondary aims include reducing MFI, enhancing healing and improving patient outcomes. VTE is defined as either symptomatic pulmonary embolism or symptomatic DVT, or ultrasound detected DVT detected at immobilization discontinuation. Patients will be randomized to the intervention or treatment-as-usual. With 90% power and an estimated 8% absolute risk reduction, a sample size of 700 patients per arm was calculated.ConclusionThe incidence of ATR in Sweden has significantly increase and continues to rise. Delayed surgical intervention negatively impacts patient-reported outcomes and should be accounted for when comparing treatment strategies. ATR immobilization increases the risk of both DVT and MFI, significantly impacting patient outcomes. Preventive measures should be prioritized to optimize patient outcomes. The STOP Leg clots study, a ongoing prospective multicenter trial, aims to mitigate these negative effects and improve long-term recovery in ATR patients.List of scientific papersI. Svedman S, Marcano A, Ackermann PW, Felländer-Tsai L, Berg HE. Acute Achilles Tendon Ruptures Between 2002-2021: Sustained Increased Incidence, Surgical Decline and Prolonged Delay to Surgery - A Nationwide Study of 53,688 Patients in Sweden. https://doi.org/10.1136/bmjsem-2024-001960II. Svedman S, Juthberg R, Edman G, Ackermann PW. Reduced Time to Surgery Improves Patient-Reported Outcome and decreases the Risk of Adverse Events after Achilles Tendon Rupture. Am. J Sports Med. 2018, 46(12), 2929-2934.https://doi.org/10.1177/0363546518793655III. Svedman S, Edman G, Ackermann PW. Deep venous thrombosis after Achilles tendon rupture is associated with poor patient- reported outcome. Knee Surg Sports Traumatol Arthrosc....

  • Open Access

    Acute Achilles tendon ruptures between 2002–2021: sustained increased incidence, surgical decline and prolonged delay to surgery—a nationwide study of 53 688 ruptures in Sweden

    by Simon Svedman, Alejandro Marcano, Paul W Ackermann, Li Felländer-Tsai, Hans Erik Berg

    Introduction Given the lack of consensus on optimal treatment strategies for acute Achilles tendon rupture (ATR), understanding temporal trends, treatment choice and demographic characteristics is important. Previous research suggests increasing incidence with declining surgical treatment. Current trends in Sweden are not known. Hypothesis/purpose To assess how incidence rates, treatment trends and time from injury to surgery (TTS) of ATR have changed between 2002 and 2021 in Sweden, with particular attention to changes since 2012. Study design Descriptive epidemiology study. Methods We conducted a nationwide register-based study including all inpatients and outpatients ≥18 years of age with an ATR between 2002 and 2021 in Sweden. Results 53 688 ATRs (78.5% men) were identified during the study period. 15 045 patients (81.5% men) were surgically treated within 30 days. The long-term incidence rate for ATR injury increased by 45%, from 28.8 in 2002 to 41.7 in 2021 per 100 000 person-years (pConclusion The observed increase in incidence rates and decrease in surgical treatment of ATR emphasise the need for evidence-based treatment and rehabilitation protocols for non-operated patients of all ages. A significant increase in time from injury to surgery was observed throughout the study period.


  • Open Access

    Long‐term patient outcome is affected by deep venous thrombosis after Achilles tendon rupture repair

    by Susanna Aufwerber, Simon Svedman, Karin Grävare Silbernagel, Paul W. Ackermann

    Purpose: The aim of the study was to examine the impact of a deep venous thrombosis (DVT) on patient outcomes 3 years after Achilles tendon rupture (ATR) repair and if there were continued improvements between 1 and 3 years after surgery. A secondary aim was to determine risk factors associated with impaired patient outcomes in the long term.Methods: This cohort study consisted of 181 ATR‐repaired patients, from two large randomized clinical trials, who attended a 3‐year follow‐up evaluation. Patients were postoperatively randomized to two different weight‐bearing interventions compared with immobilization in a below‐knee plaster cast for 2 weeks. During immobilization, screening for DVT was performed with Doppler ultrasound. At 1 and 3 years postoperatively, functional‐ and patient‐reported outcomes were evaluated by the validated heel‐rise test and self‐reported questionnaire, Achilles tendon Total Rupture Score (ATRS).Results: In total, 76 out of 181 (42%) patients exhibited a DVT at the 2‐ or 6‐week screening after ATR surgery. Suffering from a DVT during immobilization resulted at 3 years in a worse limb symmetry index (LSI) of heel‐rise total work compared to patients without DVT, adjusted for age (DVT mean LSI 68% vs. no DVT 78%, p = 0.027). At 3 years, patients with a DVT during immobilization displayed lower ATRS (DVT median 88 vs. no DVT 93, p = 0.046), which was not significant after adjustment for age. However, patients with DVT exhibited an improvement in ATRS, LSI total work, and LSI maximum height between 1 and 3 years, which was not seen among patients without DVT. Independent risk factors for reduced patient functional outcomes at 3 years were older age, greater calf muscle hypotrophy, and suffering a DVT.Conclusions: DVT during immobilization affects patients' long‐term functional outcomes 3 years after ATR repair. Clinicians should adequately address risk factors contributing to impaired patient outcomes in the long term, including calf muscle hypotrophy, DVT, and older age.Level of Evidence: Level Ⅲ.


  • Open Access

    STOP leg clots—Swedish multicentre trial of outpatient prevention of leg clots: study protocol for a randomised controlled trial on the efficacy of intermittent pneumatic compression on venous thromboembolism in lower leg immobilised patients

    by Simon Svedman, Björn Alkner, Hans E Berg, Erica Domeij-Arverud, Kenneth Jonsson, Katarina Nilsson Helander, Paul W Ackermann

    Introduction Leg immobilisation in a cast or an orthosis after lower limb injuries is associated with a high risk of complications of venous thromboembolism (VTE) and hampered healing. Current pharmacoprophylaxes of VTE are inefficient and associated with adverse events. Intermittent pneumatic compression (IPC) could represent a novel, efficient and safe VTE-prophylactic alternative that may enhance injury healing. The aim of STOP leg clots is to assess the efficacy of adjuvant IPC-therapy on reduction of VTE incidence and improvement of healing in lower leg immobilised outpatients. Methods and analysis STOP leg clots is a multicentre randomised controlled superiority trial. Eligible patients (700 patients/arm) with either an acute ankle fracture or Achilles tendon rupture will be randomised to either addition of IPC during lower-leg immobilisation or to treatment-as-usual. The primary outcome will be the total VTE incidence, that is, symptomatic and asymptomatic deep venous thrombosis (DVT) or symptomatic pulmonary embolism (PE), during the leg immobilisation period, approximately 6–8 weeks. DVT incidence will be assessed by screening whole leg compression duplex ultrasound at removal of leg immobilisation and/or clinically diagnosed within the time of immobilisation. Symptomatic PE will be verified by CT. Secondary outcomes will include patient-reported outcome using validated questionnaires, healing evaluated by measurements of tendon callus production and changes in VTE-prophylactic mechanisms assessed by blood flow and fibrinolysis. Data analyses will be blinded and based on the intention-to-treat. Ethics and dissemination Ethical approval was obtained by the ethical review board in Stockholm, Sweden, Dnr 2016/1573-31. The study will be conducted in accordance with the Helsinki declaration. The results of the study will be disseminated in peer-reviewed international journals. Trial registration NCT03259204. Time schedule 1 September 2018 to 31 December 2022


  • Open Access

    Higher pyruvate levels after Achilles tendon rupture surgery could be used as a prognostic biomarker of an improved patient outcome

    by Gianluigi Capone, Simon Svedman, Robin Juthberg, Gunnar Edman, Paul W. Ackermann

    Purpose: The primary aim of this study was to assess the relationship between the metabolites lactate and pyruvate in the healing tendon after Achilles tendon rupture (ATR) and patient‐reported outcome at 6 and 12 months. A secondary aim was to evaluate which underlying factors regulate lactate and pyruvate concentrations.Methods: Lactate and pyruvate concentrations were measured two weeks post‐operatively in both the healing‐ and healthy Achilles tendon in 109 patients (90 men, 19 women; mean age 40 ± 7.9 years). Patient demographics, degree of physical activity, timing of surgery, operation time, patient‐reported loading and step counts were investigated in relation to metabolite concentrations. At 6 and 12 months, the Achilles tendon Total Rupture Score (ATRS) questionnaire was used to assess patient outcome.Results: The mean number of steps taken during the post‐operative days 1–10 was the only factor significantly related to the mean concentration of lactate (R2 = 0.34, p = 0.038), and pyruvate (R2 = 0.46, p = 0.006). Pyruvate was demonstrated as the only factor significantly associated with ATRS at both 6 months (R2 = 0.32, p = 0.003) and at 12 months (R2 = 0.37, p = 0.004) using multiple linear regression.Conclusion: The mean concentration of pyruvate during early ATR healing may predict patient outcome at 6 and 12 months post‐operatively and possibly be used as a biomarker of healing. Early mobilization with an increased number of steps taken is an important clinical strategy to improve the metabolite concentrations during healing.Level of evidence: III


  • Open Access

    Deep venous thrombosis after Achilles tendon rupture is associated with poor patient-reported outcome

    by Simon Svedman, Gunnar Edman, Paul W. Ackermann

    Purpose: The aim of this study was to investigate whether patient subjective and functional outcomes after Achilles tendon rupture (ATR) are related to deep venous thrombosis (DVT) during leg immobilization. Methods: A cohort study with prospectively collected randomized data was conducted between 2010 and 2017. Two-hundred and fifty-one Patients with an Achilles tendon rupture (mean age = 41 ± 8), treated with uniform surgical techniques, were retrospectively analyzed. DVT incidence at 2 and 6 weeks was assessed using compression duplex ultrasound. At 12 months patient-reported outcomes were assessed using the Achilles tendon Total Rupture Score (ATRS), Foot- and Ankle Outcome Score (FAOS), Physical Activity Scale (PAS) and functional outcome with the calf-muscle endurance test. ANOVA analyses were used and adjusted for assumed confounding factors (patient age, sex, BMI and rehabilitation). Results: The total DVT incidence was 122 out of 251 (49%). Patients suffering a DVT exhibited significantly lower ATRS at 1 year compared to patients without DVT (mean 76 vs 83, 95% CI 71–79 vs 80–87; p < 0.01). Sixty-seven percent (95% CI 57–77%) of the patients devoid of DVT reported a good outcome (ATRS > 80) compared to 51% (95% CI 41–61%) of the patients sustaining a DVT (p < 0.05). Quality of life displayed significantly better outcome in the non-DVT versus DVT patients (mean = 75 (95% CI 71–79) vs. mean = 68 (95% CI 64–72); p < 0.05). A significant difference in total concentric work was observed between non-DVT and DVT patients (median = 1.9 kJ (IQR = 0.9 kJ) vs. median = 1.6 kJ (IQR = 1.0 kJ); p < 0.01). Conclusion: Sustaining a DVT during leg immobilization significantly impairs patient-reported outcome at 1 year after surgical repair of ATR. Level of evidence: III.


  • Open Access

    Longer duration of operative time enhances healing metabolites and improves patient outcome after Achilles tendon rupture surgery

    by Simon Svedman, Olof Westin, Susanna Aufwerber, Gunnar Edman, Katarina Nilsson-Helander, Michael R. Carmont, Jón Karlsson, Paul W. Ackermann

    Purpose The relationship between the duration of operative time (DOT), healing response and patient outcome has not been previously investigated. An enhanced healing response related to DOT may potentiate repair processes, especially in hypovascular and sparsely metabolized musculoskeletal tissues such as tendons. This study aimed to investigate the association between DOT and the metabolic healing response, patient-reported outcome and the rate of post-operative complications after acute Achilles tendon injury. Methods Observational cohort, cross-sectional study with observers blinded to patient grouping. A total of two-hundred and fifty-six prospectively randomized patients (210 men, 46 women; mean age 41 years) with an acute total Achilles tendon rupture all operated on with uniform anaesthetic and surgical technique were retrospectively assessed. At 2 weeks post-operatively, six metabolites were quantified using microdialysis. At 3, 6 and 12 months, patient-reported pain, walking ability and physical activity were examined using self-reported questionnaires, Achilles tendon total rupture score, foot and ankle outcome score and physical activity scale. At 12 months, functional outcome was assessed using the heel-rise test. Complications, such as deep venous thrombosis, infections and re-operations, were recorded throughout the study. Results Patients who underwent longer DOT exhibited higher levels of glutamate (p = 0.026) and glycerol (p = 0.023) at 2 weeks. At the 1-year follow-up, longer DOT was associated with significantly less loss in physical activity (p = 0.003), less pain (p = 0.009), less walking limitations (p = 0.022) and better functional outcome (p = 0.014). DOT did not significantly correlate with the rate of adverse events, such as deep venous thrombosis, infections or re-ruptures. Higher glutamate levels were associated with less loss in physical activity (p = 0.017). All correlations were confirmed by multiple linear regressions taking confounding factors into consideration. Conclusion The results from this study suggest a previously unknown mechanism, increased metabolic response associated with longer DOT, which may improve patient outcome after Achilles tendon rupture surgery. Allowing for a higher amount of traumatized tissue, as reflected by up-regulation of glycerol in patients with longer DOT, may prove to be an important surgical tip for stimulation of repair of hypometabolic soft tissue injuries, such as Achilles tendon ruptures. Level of evidence II.


  • Open Access

    Procollagen markers in microdialysate can predict patient outcome after Achilles tendon rupture

    by Abdul Alim, Simon Svedman, Gunnar Edman, Paul W Ackermann

    Objective Patients who sustain acute Achilles tendon rupture (ATR) exhibit variable and mostly impaired long-term functional, and patient-reported outcomes. However, there exists a lack of early predictive markers of long-term outcomes to facilitate the development of improved treatment methods. The aim of this study was to assess markers of tendon callus production in patients with ATR in terms of outcome, pain, and fatigue. Study design and setting Prospective cohort study; level of evidence 2. Outpatient orthopaedic/sports medicine department. Patients A total of 65 patients (57 men, 8 women; mean age 41±7 years) with ATR were prospectively assessed. Assessments Markers of tendon callus production, procollagen type I N-terminal propeptide (PINP) and procollagen type III N-terminal propeptide (PIIINP), were assessed 2 weeks postoperatively using microdialysis followed by enzymatic quantification. Normalised procollagen levels (n-PINP and n-PIIINP) were calculated as the ratio of procollagen to total protein content. Pain and fatigue were assessed at 1 year using reliable questionnaires Achilles tendon Total Rupture Score (ATRS). Results Patients exhibited fatigue (77.6%) and pain (44.1%) to some extent. Higher levels of n-PINP (R=0.38, p=0.016) and n-PIIINP (R=0.33, p=0.046) were significantly associated with less pain in the limb. Increased concentrations of PINP (R=−0.47, p=0.002) and PIIINP (R=−0.37, p=0.024) were related to more self-reported fatigue in the leg. The results were corroborated by multiple linear regression analyses. Conclusions Assessment of procollagen markers in early tendon healing can predict long-term patient-reported outcomes after ATR. These novel findings suggest that procollagen markers could be used to facilitate the development of improved treatment methods in patients who sustain ATR. Trial registration numbers NCT01317160: Results. NCT02318472: Pre-results.